Search results
Results from the WOW.Com Content Network
An experimental COVID-19 vaccine aims to get ahead of new variants by priming the immune system to recognize a stable part of the coronavirus.
A universal coronavirus vaccine, also known as a pan-coronavirus vaccine, is a theoretical coronavirus vaccine that would be effective against all coronavirus strains. A universal vaccine would provide protection against coronavirus strains that have caused disease in humans, such as SARS-CoV-2 (including all its variants), while also providing ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
PTX-COVID19-B is a messenger RNA (mRNA)-based COVID-19 vaccine, a vaccine for the prevention of the COVID-19 disease caused by an infection of the SARS-CoV-2 coronavirus, created by Providence Therapeutics—a private Canadian drug company co-founded by Calgary, Alberta-based businessman Brad T. Sorenson and San Francisco–based Eric Marcusson ...
The University of Washington epidemiologists who set up a widely watched model projecting the future course of the coronavirus outbreak have translated those projections into suggested time frames ...
The scientist who won the race to deliver the first widely used coronavirus vaccine says people can rest assured the shots are safe, and the technology behind it will soon be used to fight another ...
The COVID-19 High-Performance Computing Consortium also aims to predict the spread of disease, model possible vaccines, and study thousands of chemical compounds to develop a COVID-19 vaccine or therapy. [37] [38] As of May 2020, the Consortium has used up 437 petaFLOPS of computing power.
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL